Market Price Fluctuations and Valuation Losses on Investment Securities
First written in FY2020. 8 of 15 entries say "Materialised", first in FY2020. Latest entry: 2026-10-26.
The whole theme swung hardest in 2019: 69 of 144 companies on the "Worse" side.
- FY2026MitigatedAnnual report
「Valuation difference on other securities and the reserve for special purposes increased by ¥4.822 billion and ¥2.8 billion, respectively.」
While the previous fiscal year and earlier disclosures reported declines in losses on valuation of investment securities and valuation difference, valuation difference on other securities increased by ¥4.822 billion in the current fiscal year. - 2026-05-15MitigatedEarnings
「その他有価証券評価差額金が48億２千２百万円」
その他有価証券評価差額金が前期末から48億2,200万円増加している。 - FY2026-H1MaterialisedAnnual report
「Interim net income was ¥1.182 billion, down 16.8% year on year, as the company recorded a ¥434 million loss on valuation of investment securities during the interim accounting period.」
A ¥434 million loss on valuation of investment securities was actually recorded during the interim accounting period, highlighting the risk of losses on valuation due to fluctuations in the market prices of investment securities. - FY2025MaterialisedAnnual report
「Valuation difference on other securities decreased by ¥846 million.」
Valuation difference on other securities related to investment securities decreased by ¥846 million, reflecting the deterioration in valuations associated with market price fluctuations and other factors. - FY2024-Q3MitigatedAnnual report
「The main factors were increases of ¥2.228 billion in valuation difference on other securities and ¥1.347 billion in retained earnings, respectively, among other factors.」
Valuation difference on other securities increased by ¥2.228 billion, continuing the recovery from the decline in valuation difference through the previous fiscal year. - FY2024-Q2MitigatedAnnual report
「The main factors were increases of ¥1.47 billion in the valuation difference on available-for-sale securities and ¥369 million in retained earnings, among others.」
The valuation difference on available-for-sale securities increased by ¥1.47 billion, continuing the recovery from the decline in valuation differences through the previous fiscal year. - FY2024-Q1MitigatedAnnual report
「The main factors were an increase of ¥936 million in the valuation difference on available-for-sale securities and a decrease of ¥280 million in retained earnings, among others.」
The valuation difference on available-for-sale securities increased by ¥936 million, indicating a recovery from the decline in valuation differences disclosed through the previous fiscal year. - FY2023MitigatedAnnual report
「The valuation difference on available-for-sale securities increased by ¥312 million.」
Although valuation differences had continued to decline through the previous fiscal year, the valuation difference on available-for-sale securities increased by ¥312 million during the fiscal year, indicating a recovery in valuation differences. - FY2023-Q3Continued decrease in valuation differenceAnnual report
「The main factors were an increase of ¥1.49 billion in retained earnings and a decrease of ¥35 million in valuation difference on available-for-sale securities, among others.」
The valuation difference on available-for-sale securities decreased by ¥35 million, continuing the decline in valuation differences associated with market price fluctuations and other factors. - FY2023-Q2MaterialisedAnnual report
「The main factors were an increase of ¥581 million in retained earnings and a decrease of ¥154 million in valuation difference on available-for-sale securities, among others.」
The valuation difference on available-for-sale securities related to investment securities decreased by ¥154 million, reflecting a continued deterioration in valuations due to market price fluctuations. - FY2023-Q1MaterialisedAnnual report
「The main factors included increases of ¥403 million in construction in progress and ¥247 million in leased assets, while investment securities decreased by ¥231 million.」
Valuation differences related to investment securities declined, and the balance of investment securities also decreased by ¥231 million from the end of the previous consolidated fiscal year. - FY2022-Q3MaterialisedAnnual report
「Impairment loss on investment securities ¥44 million」
Regarding the risk of market price fluctuations and impairment losses on investment securities, an impairment loss of ¥44 million was recognized during the cumulative third quarter. - FY2020MaterialisedAnnual report
「Under extraordinary losses, the Company recorded an impairment loss on investment securities of ¥412 million.」
The risk of market price fluctuations associated with holding shares and other securities in companies with which the Company has business relationships materialized during the fiscal year, with an impairment loss on investment securities of ¥412 million recognized.